Quarterly Result2 Aug 2025, 10:01 pm
Balaji Amines Q1FY26 Revenue at ₹ 367 Crore; EBITDA at ₹ 64 Crore; Net Profit at ₹ 31 Crore
AI Summary
Balaji Amines Limited, a leading manufacturer of Aliphatic Amines & Speciality Chemicals in India, announced its unaudited financial results for the quarter ended June 30, 2025. The company's Consolidated Q1FY26 Revenue stood at ₹ 367 Crore, EBITDA at ₹ 64 Crore, and Net Profit at ₹ 31 Crore. The company's performance is supported by a disciplined working model and stable commodity prices. The company is investing in new projects and expanding its product portfolio, including Dimethyl Ether (DME), N-Methyl Morpholine (NMM), and Acetonitrile. The company is also expanding its subsidiary, Balaji Speciality Chemicals Limited, with an investment of ₹ 750 crores.
Key Highlights
- Balaji Amines Limited's Consolidated Q1FY26 Revenue stood at ₹ 367 Crore.
- EBITDA for Q1FY26 was ₹ 64 crore.
- Net Profit for Q1FY26 was ₹ 31 crore.
- The company is investing in new projects and expanding its product portfolio.
- Balaji Speciality Chemicals Limited is expanding with an investment of ₹ 750 crores.